Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial.

Ther Clin Risk Manag · 2017 · PMC5565373 · PMID 28860784

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Changes in CKD-MBD parameters Changes in serum FGF23 levels The percentage change in the serum FGF23 level showed a trend to increase more in the combination group (calcium carbonate and calcitriol) than that in the calcitriol-alone group, although the difference was not statistically significant (with and without calcium carbonate: ΔFGF23 [%] =68.9%±58.8% and 35.1%±39.1%, respectively, P =0.097; Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.